{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:31:23Z","timestamp":1769761883996,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Context<\/jats:title>\n            <jats:p>Hyperthyroidism can lead to reduced bone mineral density (BMD) and increased fracture risk particularly in postmenopausal women, but the mechanism behind is still unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Prospective examination of the influence of thyroid hormones and\/or thyroid autoantibodies on BMD in premenopause.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design<\/jats:title>\n            <jats:p>We have examined 32 premenopausal women with untreated active Graves' disease from time of diagnosis, during 18 months of antithyroid drug therapy (ATD) and additionally 18 months after discontinuing ATD. Variables of thyroid metabolism, calcium homeostasis and body composition were measured every 3 months. BMD of lumbar spine and femoral neck were measured at baseline, 18 \u00b1 3 and 36 \u00b1 3 months. Data were compared to base line, a sex- and age matched control group and a group of patients with Hashimoto's thyroiditis treated with non-suppressive doses of levothyroxine.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study showed significantly (p &lt; 0.002) lower BMD in the thyrotoxic state compared to the control group with subsequent significant improvement during 18 \u00b1 3 months of ATD compared to baseline (p &lt; 0.001). However, during the following 18 months after stopping ATD femoral neck BMD decreased again unrelated to age (more than 0.4% per year, p &lt; 0,002). The wellestablished effect of thyrotoxicosis on calcium homeostasis was confirmed. The positive predictor for best BMD was TSH receptor antibodies (TRAb) while free T4 correlated negatively in the thyrotoxic female Graves' patients (p &lt; 0.02 and p &lt; 0.003). In healthy controls and patients with treated Graves' disease both TSH and T4 correlated negatively to the bone mass (BMC) (p &lt; 0.003).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The results indicated a clinically relevant impact of thyroid function on bone modulation also in premenopausal women with Graves' disease, and further indicated the possibility for a direct action of TRAb on bones.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-7075-7-72","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T06:15:36Z","timestamp":1283321736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?"],"prefix":"10.1186","volume":"7","author":[{"given":"Tina Z","family":"Belsing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Tofteng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bente L","family":"Langdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peder","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,1]]},"reference":[{"key":"284_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0889-8529(18)30338-4","volume":"19","author":"L Mosekilde","year":"1990","unstructured":"Mosekilde L, Eriksen EF, Charles P: Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am. 1990, 19: 35-63.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"284_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/105072503322238854","volume":"13","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard P, Mosekilde L: Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis. Thyroid. 2003, 13: 585-593. 10.1089\/105072503322238854.","journal-title":"Thyroid"},{"key":"284_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/105072502760043503","volume":"12","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Mosekilde L: Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid. 2002, 12: 411-419. 10.1089\/105072502760043503.","journal-title":"Thyroid"},{"key":"284_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/thy.2000.10.341","volume":"10","author":"P Vestergaard","year":"2000","unstructured":"Vestergaard P, Rejnmark L, Weeke J, Mosekilde L: Fracture risk in patients treated for hyperthyroidism. Thyroid. 2000, 10: 341-348. 10.1089\/thy.2000.10.341.","journal-title":"Thyroid"},{"key":"284_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1056\/NEJM199503233321202","volume":"332","author":"SR Cummings","year":"1995","unstructured":"Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995, 332: 767-773. 10.1056\/NEJM199503233321202.","journal-title":"N Engl J Med"},{"key":"284_CR6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1210\/jcem-70-3-766","volume":"70","author":"MS Lee","year":"1990","unstructured":"Lee MS, Kim SY, Lee MC, Cho BY, Lee HK, Koh CS, Min HK: Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab. 1990, 70: 766-770. 10.1210\/jcem-70-3-766.","journal-title":"J Clin Endocrinol Metab"},{"key":"284_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00198-006-0091-4","volume":"17","author":"T Majima","year":"2006","unstructured":"Majima T, Komatsu Y, Doi K, Takagi C, Shigemoto M, Fukao A, Morimoto T, Corners J, Nakao K: Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease. Osteoporos Int. 2006, 17: 1103-1110. 10.1007\/s00198-006-0091-4.","journal-title":"Osteoporos Int"},{"key":"284_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S8756-3282(96)00247-5","volume":"19","author":"BL Langdahl","year":"1996","unstructured":"Langdahl BL, Loft AG, Moller N, Weeke J, Eriksen EF, Mosekilde L, Charles P: Skeletal responsiveness to thyroid hormone is not altered at menopause. Bone. 1996, 19: 557-564. 10.1016\/S8756-3282(96)00247-5.","journal-title":"Bone"},{"key":"284_CR9","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1210\/jcem.82.6.4026","volume":"82","author":"E Jodar","year":"1997","unstructured":"Jodar E, Munoz-Torres M, Escobar-Jimenez F, Quesada M, Luna JD, Olea N: Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism. J Clin Endocrinol Metab. 1997, 82: 1989-1994. 10.1210\/jc.82.6.1989.","journal-title":"J Clin Endocrinol Metab"},{"key":"284_CR10","first-page":"201","volume":"7","author":"CG Acotto","year":"2004","unstructured":"Acotto CG, Niepomniszcze H, Vega E, Mautalen CA: Thyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med. 2004, 7: 201-208.","journal-title":"Ann Intern Med"},{"key":"284_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7326\/0003-4819-120-1-199401010-00002","volume":"120","author":"T Diamond","year":"1994","unstructured":"Diamond T, Vine J, Smart R, Butler P: Thyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med. 1994, 120: 8-11.","journal-title":"Ann Intern Med"},{"key":"284_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/jc.82.3.753","volume":"82","author":"A Siddiqi","year":"1997","unstructured":"Siddiqi A, Burrin JM, Noonan K, James I, Wood DF, Price CP, Monson JP: A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral. J Clin Endocrinol metab. 1997, 82: 753-759. 10.1210\/jc.82.3.753.","journal-title":"J Clin Endocrinol metab"},{"key":"284_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/thy.1994.4.179","volume":"4","author":"M Wakasugi","year":"1994","unstructured":"Wakasugi M, Wakao R, Tawata M, Gan N, Inoue M, Koizumi K, Onaya T: Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy X-ray absorptiometry. Thyroid. 1994, 4: 179-182. 10.1089\/thy.1994.4.179.","journal-title":"Thyroid"},{"key":"284_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2265.2004.02110.x","volume":"61","author":"H Karga","year":"2004","unstructured":"Karga H, Papapetrou PD, Korakovouni A, Papandroulaki F, Polymeris A, Pamouuras G: Bone mineral density in hyperthyroidism. Clin Endo. 2004, 61: 466-472. 10.1111\/j.1365-2265.2004.02110.x.","journal-title":"Clin Endo"},{"key":"284_CR15","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1210\/jc.75.6.1531","volume":"75","author":"CJ Rosen","year":"1992","unstructured":"Rosen CJ, Adler RA: Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab. 1992, 75: 1531-1534. 10.1210\/jc.75.6.1531.","journal-title":"J Clin Endocrinol Metab"},{"key":"284_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-2007-978666","volume":"32","author":"M Schott","year":"2000","unstructured":"Schott M, Feldkamp J, Bathan C, Fritzen R, Scherbaum WA, Seissler J: Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation. Horm Metab Res. 2000, 32: 429-435. 10.1055\/s-2007-978666.","journal-title":"Horm Metab Res"},{"key":"284_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0009-8981(00)00385-5","volume":"304","author":"C Massart","year":"2001","unstructured":"Massart C, Orgiazzi J, Maugendre D: Clinical validity of a new commercial method for detection of TSH- receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs. Clin Chim Acta. 2001, 304: 39-47. 10.1016\/S0009-8981(00)00385-5.","journal-title":"Clin Chim Acta"},{"key":"284_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/08916939109007650","volume":"9","author":"U Feldt-Rasmussen","year":"1991","unstructured":"Feldt-Rasmussen U, Hoier-Madsen M, Bech K, Blichert-Toft M, Bliddal H, Date J, Danneskiold-Samsoe B, Hegedus L, Hippe E, Hornnes PJ: Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases. Autoimmunity. 1991, 9: 245-254. 10.3109\/08916939109007650.","journal-title":"Autoimmunity"},{"key":"284_CR19","first-page":"E740","volume":"254","author":"H Daugaard","year":"1988","unstructured":"Daugaard H, Egfjord M, Olgaard K: Metabolism of intact parathyroid hormone in isolated perfused rat liver and kidney. Am J Physiol. 1988, 254: E740-E748.","journal-title":"Am J Physiol"},{"key":"284_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/ndt\/17.5.829","volume":"17","author":"L Brandi","year":"2002","unstructured":"Brandi L, Egfjord M, Olgaard K: Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic men. Nephrol Dial Transplant. 2002, 17: 829-842. 10.1093\/ndt\/17.5.829.","journal-title":"Nephrol Dial Transplant"},{"key":"284_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1046\/j.1365-2265.1998.00627.x","volume":"49","author":"T Zimmermann-Belsing","year":"1998","unstructured":"Zimmermann-Belsing T, Dreyer M, Holst JJ, Feldt-Rasmussen U: The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects. Clin Endocrinol (Oxf). 1998, 49: 589-595. 10.1046\/j.1365-2265.1998.00627.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"284_CR22","first-page":"99","volume":"10","author":"PK Nielsen","year":"1994","unstructured":"Nielsen PK, Ladefoged J, Olgaard K: Lean body mass by Dual Energy X-ray Absorptiometry (DEXA) and by urine and dialysate creatinine recovery in CAPD and pre-dialysis patients compared to normal subjects. Adv Perit Dial. 1994, 10: 99-103.","journal-title":"Adv Perit Dial"},{"key":"284_CR23","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1359\/jbmr.1997.12.8.1316","volume":"12","author":"J Hanson","year":"1997","unstructured":"Hanson J: Standardization of femur BMD. J Bone Miner Res. 1997, 12: 1316-1317. 10.1359\/jbmr.1997.12.8.1316.","journal-title":"J Bone Miner Res"},{"key":"284_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/BF00301953","volume":"57","author":"P Steiger","year":"1995","unstructured":"Steiger P: Standardization of measurements for assessing BMD by DXA. Calcif Tissue Int. 1995, 57: 469-477. 10.1007\/BF00301953.","journal-title":"Calcif Tissue Int"},{"key":"284_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bone.2008.06.001","volume":"43","author":"WD Leslie","year":"2008","unstructured":"Leslie WD, Tsang JF, Lix LM: Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program. Bone. 2008, 43: 667-671. 10.1016\/j.bone.2008.06.001.","journal-title":"Bone"},{"key":"284_CR26","first-page":"1","volume-title":"Festschrift Rudolph Virchow","author":"FC Von Recklinghausen","year":"1891","unstructured":"Von Recklinghausen FC: Die fibrose oder deformierende ostitis, die osteomalazie und die osteoplastische karzinose in ihren gegenseitigen beziehungen. Festschrift Rudolph Virchow. 1891, Berlin: G Reimer, 1-89."},{"key":"284_CR27","doi-asserted-by":"publisher","first-page":"750","DOI":"10.7326\/0003-4819-130-9-199905040-00016","volume":"130","author":"SL Greenspan","year":"1999","unstructured":"Greenspan SL, Greenspan FS: The effect of thyroid hormone on skeletal integrity. Ann Intern Med. 1999, 130: 750-758.","journal-title":"Ann Intern Med"},{"key":"284_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00223-005-0068-x","volume":"77","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L: Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int. 2005, 77: 139-144. 10.1007\/s00223-005-0068-x.","journal-title":"Calcif Tissue Int"},{"key":"284_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/8756-3282(85)90218-2","volume":"6","author":"EF Eriksen","year":"1985","unstructured":"Eriksen EF, Mosekilde L, Melsen F: Trabecular bone remodeling and bone balance in hyperthyroidism. Bone. 1985, 6: 421-428. 10.1016\/8756-3282(85)90218-2.","journal-title":"Bone"},{"key":"284_CR30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1530\/acta.0.0850515","volume":"85","author":"L Mosekilde","year":"1977","unstructured":"Mosekilde L, Melsen F, Bagger JP, Myhre-Jensen O, Schwartz SN: Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol (Copenh). 1977, 85: 515-525.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"284_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S8756-3282(97)00097-5","volume":"21","author":"EO Abu","year":"1997","unstructured":"Abu EO, Bord S, Horner A, Chatterjee VK, Compston JE: The expression of thyroid hormone receptors in human bone. Bone. 1997, 21: 137-142. 10.1016\/S8756-3282(97)00097-5.","journal-title":"Bone"},{"key":"284_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0092-8674(03)00771-2","volume":"115","author":"E Abe","year":"2003","unstructured":"Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M: TSH is a negative regulator of skeletal remodeling. Cell. 2003, 115: 151-162. 10.1016\/S0092-8674(03)00771-2.","journal-title":"Cell"},{"key":"284_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1359\/jbmr.070302","volume":"22","author":"TK Sampath","year":"2007","unstructured":"Sampath TK, Simic P, Sendac R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S: Thyroid stimulating hormone restoresbone volume microarchitecture, and strength in ovariectomised. J Bone Mineral Res. 2007, 22: 849-859. 10.1359\/jbmr.070302.","journal-title":"J Bone Mineral Res"},{"key":"284_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1196\/annals.1346.033","volume":"1068","author":"L Sun","year":"2006","unstructured":"Sun L, Davies TF, Blair HC, Abe E, Zaidi M: TSH and bone loss. Ann N Y Acad Sci. 2006, 1068: 309-318. 10.1196\/annals.1346.033.","journal-title":"Ann N Y Acad Sci"},{"key":"284_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00774-009-0098-y","volume":"28","author":"H Karga","year":"2010","unstructured":"Karga H, Papaioannou G, Polymeris A, Papamichael K, Karpouza A, Samouilidou E, Papaioannou P: The effects of recombinant human TSH on bone turnover in patients after thyroidectomy. J Bone Miner Metab. 2010, 28: 35-41. 10.1007\/s00774-009-0098-y.","journal-title":"J Bone Miner Metab"},{"key":"284_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00223-003-0108-3","volume":"74","author":"JA Tsai","year":"2004","unstructured":"Tsai JA, Janson A, Bucht E, Kindmark H, Marcus C, Stark A, Zemach HR, Torring O: Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells. calcif Tissue Int. 2004, 74: 486-491. 10.1007\/s00223-003-0108-3.","journal-title":"calcif Tissue Int"},{"key":"284_CR37","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1210\/en.2004-1432","volume":"146","author":"T Morimura","year":"2005","unstructured":"Morimura T, Tsunekawa K, Kasahara T, Seki K, Ogiwara T, Mori M, Murakami M: Expression of type 2 iodothyronine deiodinase in human osteoblast is stimulated by thyrotropin. Endocrinology. 2005, 146: 2077-2084. 10.1210\/en.2004-1432.","journal-title":"Endocrinology"},{"key":"284_CR38","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1210\/me.2007-0033","volume":"21","author":"JH Bassett","year":"2007","unstructured":"Bassett JH, O'Shea PJ, Sriskantharajah S, Rabier B, Boyde A, Howell PG, Weiss RE, Roux JP, Malaval L, Clement-Lacroix P, Samarut J, Chassande O, Williams GR: Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol. 2007, 21: 1095-1107. 10.1210\/me.2007-0033.","journal-title":"Mol Endocrinol"},{"key":"284_CR39","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.bone.2006.12.001","volume":"40","author":"MS Morris","year":"2007","unstructured":"Morris MS: The association betweenthyroid-stimulating hormone in its reference range and bone status in postmenopausal American. Bone. 2007, 40: 1128-1134. 10.1016\/j.bone.2006.12.001.","journal-title":"Bone"},{"key":"284_CR40","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1089\/thy.2008.0158","volume":"18","author":"G Grimnes","year":"2008","unstructured":"Grimnes G, Emaus N, Joakimsen RN, Figenschau Y, Jorde R: The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Troms\u00f8 study. Thyroid. 2008, 18: 1147-1155. 10.1089\/thy.2008.0158.","journal-title":"Thyroid"},{"key":"284_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-2265.1993.tb01007.x","volume":"38","author":"M Wakasugi","year":"1993","unstructured":"Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T: Bone mineral density in patients with hyperthyroidism measured by dual energy X-ray absorptiometry. Clin Endocrinol (Oxf). 1993, 38: 283-286. 10.1111\/j.1365-2265.1993.tb01007.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"284_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1046\/j.1365-2265.1997.2261041.x","volume":"47","author":"E Jodar","year":"1997","unstructured":"Jodar E, Munoz-Torres M, Escobar-Jimenez F, Quesada-Charneco M, Lund del Castillo JD: Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause. Clin Endocrinol (Oxf). 1997, 47: 279-285. 10.1046\/j.1365-2265.1997.2261041.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"284_CR43","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1210\/jc.85.11.4157","volume":"85","author":"Y Kumeda","year":"2000","unstructured":"Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y: Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. J Clin Endocrinol Metab. 2000, 85: 4157-4161. 10.1210\/jc.85.11.4157.","journal-title":"J Clin Endocrinol Metab"},{"key":"284_CR44","volume-title":"The thyroid and its diseases","author":"LJ De Groot","year":"2000","unstructured":"De Groot LJ, Larsen PR, Hennemann G: The thyroid and its diseases. 2000"},{"key":"284_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/105072503321086962","volume":"13","author":"Z Baloch","year":"2003","unstructured":"Baloch Z, Carayon P, Conte-Delvolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR: Laboratory medicine practice guidelines. laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003, 13: 3-126. 10.1089\/105072503321086962.","journal-title":"Thyroid"},{"key":"284_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1530\/EJE-09-0160","volume":"161","author":"NO Klefter","year":"2009","unstructured":"Klefter NO, Feldt-Rasmussen U: Is increase in bone mineral content caused by increase in skeletal muscle mass\/strength in adult patients with GH-treated GH deficiency? A systematic literature analysis. Eur J Endocrinol. 2009, 161: 213-221. 10.1530\/EJE-09-0160.","journal-title":"Eur J Endocrinol"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-7075-7-72.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:44:56Z","timestamp":1630471496000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/1743-7075-7-72"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["284"],"URL":"https:\/\/doi.org\/10.1186\/1743-7075-7-72","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,1]]},"assertion":[{"value":"4 March 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"72"}}